Global Prenatal Cell-Free DNA Screening Market Growth (Status and Outlook) 2026-2032
The global Prenatal Cell-Free DNA Screening market size is predicted to grow from US$ 755 million in 2025 to US$ 1415 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
Prenatal Cell-Free DNA Screening refers to a prenatal screening approach that analyzes fetal genetic signals present as cell-free DNA fragments in a pregnant individual’s blood sample to estimate the risk of specific fetal genetic abnormalities without invasive procedures. The process involves standardized sample collection, laboratory analysis, computational interpretation, and structured clinical reporting, with results used to guide decisions about confirmatory diagnostic testing and ongoing prenatal care management. It is designed as a screening tool rather than a definitive diagnosis, and its clinical value depends on analytical accuracy, quality assurance, and responsible interpretation within established prenatal counseling and follow-up workflows.
Prenatal Cell-Free DNA Screening is now widely viewed as the most scalable pathway to bring DNA-based risk assessment into routine prenatal care, because it combines a noninvasive workflow with high-throughput laboratory operations and standardized reporting. From a research report perspective, the market is driven by continued substitution away from traditional serum-based screening, broader clinical acceptance of clear follow-up pathways, and ongoing improvements in bioinformatics and quality control that reduce test failures and strengthen performance in challenging samples. Competitive differentiation is increasingly defined by reliability at scale, analytical robustness under low fetal signal conditions, transparent clinical limitations, and the provider’s ability to integrate ordering, consent, reporting, and genetic counseling into a cohesive service model. At the same time, payer policy and regulatory scrutiny are shaping market structure, favoring providers that can demonstrate strong clinical validation, consistent end-to-end execution, and disciplined expansion of test scope without compromising interpretability or clinical governance.
LPI (LP Information)' newest research report, the “Prenatal Cell-Free DNA Screening Industry Forecast” looks at past sales and reviews total world Prenatal Cell-Free DNA Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Prenatal Cell-Free DNA Screening sales for 2026 through 2032. With Prenatal Cell-Free DNA Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Cell-Free DNA Screening industry.
This Insight Report provides a comprehensive analysis of the global Prenatal Cell-Free DNA Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal Cell-Free DNA Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal Cell-Free DNA Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Cell-Free DNA Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Cell-Free DNA Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Cell-Free DNA Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prenatal Cell-Free DNA Screening refers to a prenatal screening approach that analyzes fetal genetic signals present as cell-free DNA fragments in a pregnant individual’s blood sample to estimate the risk of specific fetal genetic abnormalities without invasive procedures. The process involves standardized sample collection, laboratory analysis, computational interpretation, and structured clinical reporting, with results used to guide decisions about confirmatory diagnostic testing and ongoing prenatal care management. It is designed as a screening tool rather than a definitive diagnosis, and its clinical value depends on analytical accuracy, quality assurance, and responsible interpretation within established prenatal counseling and follow-up workflows.
Prenatal Cell-Free DNA Screening is now widely viewed as the most scalable pathway to bring DNA-based risk assessment into routine prenatal care, because it combines a noninvasive workflow with high-throughput laboratory operations and standardized reporting. From a research report perspective, the market is driven by continued substitution away from traditional serum-based screening, broader clinical acceptance of clear follow-up pathways, and ongoing improvements in bioinformatics and quality control that reduce test failures and strengthen performance in challenging samples. Competitive differentiation is increasingly defined by reliability at scale, analytical robustness under low fetal signal conditions, transparent clinical limitations, and the provider’s ability to integrate ordering, consent, reporting, and genetic counseling into a cohesive service model. At the same time, payer policy and regulatory scrutiny are shaping market structure, favoring providers that can demonstrate strong clinical validation, consistent end-to-end execution, and disciplined expansion of test scope without compromising interpretability or clinical governance.
LPI (LP Information)' newest research report, the “Prenatal Cell-Free DNA Screening Industry Forecast” looks at past sales and reviews total world Prenatal Cell-Free DNA Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Prenatal Cell-Free DNA Screening sales for 2026 through 2032. With Prenatal Cell-Free DNA Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Cell-Free DNA Screening industry.
This Insight Report provides a comprehensive analysis of the global Prenatal Cell-Free DNA Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal Cell-Free DNA Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal Cell-Free DNA Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Cell-Free DNA Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Cell-Free DNA Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Cell-Free DNA Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Core Condition Screening
- Expanded Condition Screening
- Whole Genome Sequencing
- Targeted Sequencing
- Others
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prenatal Cell-Free DNA Screening Market Size (2021-2032)
2.1.2 Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Prenatal Cell-Free DNA Screening by Country/Region (2021, 2025 & 2032)
2.2 Prenatal Cell-Free DNA Screening Segment by Type
2.2.1 Combined First Trimester Screening
2.2.2 Second Trimester Maternal Serum Screening
2.2.3 Prenatal Cell-Free DNA Screening Market Size by Type
2.2.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
2.3 Prenatal Cell-Free DNA Screening Segment by Application
2.3.1 Diagnostic Laboratories
2.3.2 Hospitals
2.3.3 Prenatal Cell-Free DNA Screening Market Size by Application
2.3.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
3 PRENATAL CELL-FREE DNA SCREENING MARKET SIZE BY PLAYER
3.1 Prenatal Cell-Free DNA Screening Market Size Market Share by Player
3.1.1 Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026)
3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
3.2 Global Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRENATAL CELL-FREE DNA SCREENING BY REGION
4.1 Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
4.2 Global Prenatal Cell-Free DNA Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.4 APAC Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.5 Europe Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
5.2 Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
5.3 Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
6.2 APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
6.3 APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
7.2 Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prenatal Cell-Free DNA Screening by Region (2021-2026)
8.2 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRENATAL CELL-FREE DNA SCREENING MARKET FORECAST
10.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.2 Americas Prenatal Cell-Free DNA Screening Forecast
10.1.3 APAC Prenatal Cell-Free DNA Screening Forecast
10.1.4 Europe Prenatal Cell-Free DNA Screening Forecast
10.1.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast
10.2 Americas Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.2.1 United States Market Prenatal Cell-Free DNA Screening Forecast
10.2.2 Canada Market Prenatal Cell-Free DNA Screening Forecast
10.2.3 Mexico Market Prenatal Cell-Free DNA Screening Forecast
10.2.4 Brazil Market Prenatal Cell-Free DNA Screening Forecast
10.3 APAC Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.3.1 China Prenatal Cell-Free DNA Screening Market Forecast
10.3.2 Japan Market Prenatal Cell-Free DNA Screening Forecast
10.3.3 Korea Market Prenatal Cell-Free DNA Screening Forecast
10.3.4 Southeast Asia Market Prenatal Cell-Free DNA Screening Forecast
10.3.5 India Market Prenatal Cell-Free DNA Screening Forecast
10.3.6 Australia Market Prenatal Cell-Free DNA Screening Forecast
10.4 Europe Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Prenatal Cell-Free DNA Screening Forecast
10.4.2 France Market Prenatal Cell-Free DNA Screening Forecast
10.4.3 UK Market Prenatal Cell-Free DNA Screening Forecast
10.4.4 Italy Market Prenatal Cell-Free DNA Screening Forecast
10.4.5 Russia Market Prenatal Cell-Free DNA Screening Forecast
10.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Prenatal Cell-Free DNA Screening Forecast
10.5.2 South Africa Market Prenatal Cell-Free DNA Screening Forecast
10.5.3 Israel Market Prenatal Cell-Free DNA Screening Forecast
10.5.4 Turkey Market Prenatal Cell-Free DNA Screening Forecast
10.6 Global Prenatal Cell-Free DNA Screening Forecast by Type (2027-2032)
10.7 Global Prenatal Cell-Free DNA Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Prenatal Cell-Free DNA Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 Yourgene Health
11.1.1 Yourgene Health Company Information
11.1.2 Yourgene Health Prenatal Cell-Free DNA Screening Product Offered
11.1.3 Yourgene Health Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Yourgene Health Main Business Overview
11.1.5 Yourgene Health Latest Developments
11.2 Illumina Inc
11.2.1 Illumina Inc Company Information
11.2.2 Illumina Inc Prenatal Cell-Free DNA Screening Product Offered
11.2.3 Illumina Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Illumina Inc Main Business Overview
11.2.5 Illumina Inc Latest Developments
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Information
11.3.2 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product Offered
11.3.3 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Agilent Technologies Inc Main Business Overview
11.3.5 Agilent Technologies Inc Latest Developments
11.4 Thermo Fisher Scientific Inc
11.4.1 Thermo Fisher Scientific Inc Company Information
11.4.2 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product Offered
11.4.3 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Inc Main Business Overview
11.4.5 Thermo Fisher Scientific Inc Latest Developments
11.5 Hoffmann-La Roche Ltd
11.5.1 Hoffmann-La Roche Ltd Company Information
11.5.2 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product Offered
11.5.3 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hoffmann-La Roche Ltd Main Business Overview
11.5.5 Hoffmann-La Roche Ltd Latest Developments
11.6 Laboratory Corporation of America Holdings
11.6.1 Laboratory Corporation of America Holdings Company Information
11.6.2 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product Offered
11.6.3 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Laboratory Corporation of America Holdings Main Business Overview
11.6.5 Laboratory Corporation of America Holdings Latest Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Prenatal Cell-Free DNA Screening Product Offered
11.7.3 GE Healthcare Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 GE Healthcare Main Business Overview
11.7.5 GE Healthcare Latest Developments
11.8 PerkinElmer Inc
11.8.1 PerkinElmer Inc Company Information
11.8.2 PerkinElmer Inc Prenatal Cell-Free DNA Screening Product Offered
11.8.3 PerkinElmer Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 PerkinElmer Inc Main Business Overview
11.8.5 PerkinElmer Inc Latest Developments
11.9 BGI
11.9.1 BGI Company Information
11.9.2 BGI Prenatal Cell-Free DNA Screening Product Offered
11.9.3 BGI Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BGI Main Business Overview
11.9.5 BGI Latest Developments
11.10 Natera Inc
11.10.1 Natera Inc Company Information
11.10.2 Natera Inc Prenatal Cell-Free DNA Screening Product Offered
11.10.3 Natera Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Natera Inc Main Business Overview
11.10.5 Natera Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prenatal Cell-Free DNA Screening Market Size (2021-2032)
2.1.2 Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Prenatal Cell-Free DNA Screening by Country/Region (2021, 2025 & 2032)
2.2 Prenatal Cell-Free DNA Screening Segment by Type
2.2.1 Combined First Trimester Screening
2.2.2 Second Trimester Maternal Serum Screening
2.2.3 Prenatal Cell-Free DNA Screening Market Size by Type
2.2.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
2.3 Prenatal Cell-Free DNA Screening Segment by Application
2.3.1 Diagnostic Laboratories
2.3.2 Hospitals
2.3.3 Prenatal Cell-Free DNA Screening Market Size by Application
2.3.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
3 PRENATAL CELL-FREE DNA SCREENING MARKET SIZE BY PLAYER
3.1 Prenatal Cell-Free DNA Screening Market Size Market Share by Player
3.1.1 Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026)
3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
3.2 Global Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRENATAL CELL-FREE DNA SCREENING BY REGION
4.1 Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
4.2 Global Prenatal Cell-Free DNA Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.4 APAC Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.5 Europe Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
5.2 Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
5.3 Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
6.2 APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
6.3 APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
7.2 Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prenatal Cell-Free DNA Screening by Region (2021-2026)
8.2 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRENATAL CELL-FREE DNA SCREENING MARKET FORECAST
10.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.2 Americas Prenatal Cell-Free DNA Screening Forecast
10.1.3 APAC Prenatal Cell-Free DNA Screening Forecast
10.1.4 Europe Prenatal Cell-Free DNA Screening Forecast
10.1.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast
10.2 Americas Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.2.1 United States Market Prenatal Cell-Free DNA Screening Forecast
10.2.2 Canada Market Prenatal Cell-Free DNA Screening Forecast
10.2.3 Mexico Market Prenatal Cell-Free DNA Screening Forecast
10.2.4 Brazil Market Prenatal Cell-Free DNA Screening Forecast
10.3 APAC Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.3.1 China Prenatal Cell-Free DNA Screening Market Forecast
10.3.2 Japan Market Prenatal Cell-Free DNA Screening Forecast
10.3.3 Korea Market Prenatal Cell-Free DNA Screening Forecast
10.3.4 Southeast Asia Market Prenatal Cell-Free DNA Screening Forecast
10.3.5 India Market Prenatal Cell-Free DNA Screening Forecast
10.3.6 Australia Market Prenatal Cell-Free DNA Screening Forecast
10.4 Europe Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Prenatal Cell-Free DNA Screening Forecast
10.4.2 France Market Prenatal Cell-Free DNA Screening Forecast
10.4.3 UK Market Prenatal Cell-Free DNA Screening Forecast
10.4.4 Italy Market Prenatal Cell-Free DNA Screening Forecast
10.4.5 Russia Market Prenatal Cell-Free DNA Screening Forecast
10.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Prenatal Cell-Free DNA Screening Forecast
10.5.2 South Africa Market Prenatal Cell-Free DNA Screening Forecast
10.5.3 Israel Market Prenatal Cell-Free DNA Screening Forecast
10.5.4 Turkey Market Prenatal Cell-Free DNA Screening Forecast
10.6 Global Prenatal Cell-Free DNA Screening Forecast by Type (2027-2032)
10.7 Global Prenatal Cell-Free DNA Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Prenatal Cell-Free DNA Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 Yourgene Health
11.1.1 Yourgene Health Company Information
11.1.2 Yourgene Health Prenatal Cell-Free DNA Screening Product Offered
11.1.3 Yourgene Health Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Yourgene Health Main Business Overview
11.1.5 Yourgene Health Latest Developments
11.2 Illumina Inc
11.2.1 Illumina Inc Company Information
11.2.2 Illumina Inc Prenatal Cell-Free DNA Screening Product Offered
11.2.3 Illumina Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Illumina Inc Main Business Overview
11.2.5 Illumina Inc Latest Developments
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Information
11.3.2 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product Offered
11.3.3 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Agilent Technologies Inc Main Business Overview
11.3.5 Agilent Technologies Inc Latest Developments
11.4 Thermo Fisher Scientific Inc
11.4.1 Thermo Fisher Scientific Inc Company Information
11.4.2 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product Offered
11.4.3 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Inc Main Business Overview
11.4.5 Thermo Fisher Scientific Inc Latest Developments
11.5 Hoffmann-La Roche Ltd
11.5.1 Hoffmann-La Roche Ltd Company Information
11.5.2 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product Offered
11.5.3 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hoffmann-La Roche Ltd Main Business Overview
11.5.5 Hoffmann-La Roche Ltd Latest Developments
11.6 Laboratory Corporation of America Holdings
11.6.1 Laboratory Corporation of America Holdings Company Information
11.6.2 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product Offered
11.6.3 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Laboratory Corporation of America Holdings Main Business Overview
11.6.5 Laboratory Corporation of America Holdings Latest Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Prenatal Cell-Free DNA Screening Product Offered
11.7.3 GE Healthcare Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 GE Healthcare Main Business Overview
11.7.5 GE Healthcare Latest Developments
11.8 PerkinElmer Inc
11.8.1 PerkinElmer Inc Company Information
11.8.2 PerkinElmer Inc Prenatal Cell-Free DNA Screening Product Offered
11.8.3 PerkinElmer Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 PerkinElmer Inc Main Business Overview
11.8.5 PerkinElmer Inc Latest Developments
11.9 BGI
11.9.1 BGI Company Information
11.9.2 BGI Prenatal Cell-Free DNA Screening Product Offered
11.9.3 BGI Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BGI Main Business Overview
11.9.5 BGI Latest Developments
11.10 Natera Inc
11.10.1 Natera Inc Company Information
11.10.2 Natera Inc Prenatal Cell-Free DNA Screening Product Offered
11.10.3 Natera Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Natera Inc Main Business Overview
11.10.5 Natera Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Prenatal Cell-Free DNA Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Combined First Trimester Screening
Table 4. Major Players of Second Trimester Maternal Serum Screening
Table 5. Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 8. Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 11. Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
Table 13. Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
Table 14. Prenatal Cell-Free DNA Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 19. Global Prenatal Cell-Free DNA Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 23. Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 25. Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 27. APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 29. APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 33. Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Prenatal Cell-Free DNA Screening
Table 39. Key Market Challenges & Risks of Prenatal Cell-Free DNA Screening
Table 40. Key Industry Trends of Prenatal Cell-Free DNA Screening
Table 41. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Yourgene Health Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 46. Yourgene Health Prenatal Cell-Free DNA Screening Product Offered
Table 47. Yourgene Health Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Yourgene Health Main Business
Table 49. Yourgene Health Latest Developments
Table 50. Illumina Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 51. Illumina Inc Prenatal Cell-Free DNA Screening Product Offered
Table 52. Illumina Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Illumina Inc Main Business
Table 54. Illumina Inc Latest Developments
Table 55. Agilent Technologies Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 56. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product Offered
Table 57. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Agilent Technologies Inc Main Business
Table 59. Agilent Technologies Inc Latest Developments
Table 60. Thermo Fisher Scientific Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product Offered
Table 62. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Inc Main Business
Table 64. Thermo Fisher Scientific Inc Latest Developments
Table 65. Hoffmann-La Roche Ltd Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 66. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product Offered
Table 67. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Hoffmann-La Roche Ltd Main Business
Table 69. Hoffmann-La Roche Ltd Latest Developments
Table 70. Laboratory Corporation of America Holdings Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 71. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product Offered
Table 72. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Laboratory Corporation of America Holdings Main Business
Table 74. Laboratory Corporation of America Holdings Latest Developments
Table 75. GE Healthcare Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 76. GE Healthcare Prenatal Cell-Free DNA Screening Product Offered
Table 77. GE Healthcare Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. GE Healthcare Main Business
Table 79. GE Healthcare Latest Developments
Table 80. PerkinElmer Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 81. PerkinElmer Inc Prenatal Cell-Free DNA Screening Product Offered
Table 82. PerkinElmer Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. PerkinElmer Inc Main Business
Table 84. PerkinElmer Inc Latest Developments
Table 85. BGI Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 86. BGI Prenatal Cell-Free DNA Screening Product Offered
Table 87. BGI Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. BGI Main Business
Table 89. BGI Latest Developments
Table 90. Natera Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 91. Natera Inc Prenatal Cell-Free DNA Screening Product Offered
Table 92. Natera Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Natera Inc Main Business
Table 94. Natera Inc Latest Developments
Table 1. Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Prenatal Cell-Free DNA Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Combined First Trimester Screening
Table 4. Major Players of Second Trimester Maternal Serum Screening
Table 5. Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 8. Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 11. Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
Table 13. Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
Table 14. Prenatal Cell-Free DNA Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 19. Global Prenatal Cell-Free DNA Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 23. Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 25. Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 27. APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 29. APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 33. Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Prenatal Cell-Free DNA Screening
Table 39. Key Market Challenges & Risks of Prenatal Cell-Free DNA Screening
Table 40. Key Industry Trends of Prenatal Cell-Free DNA Screening
Table 41. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Yourgene Health Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 46. Yourgene Health Prenatal Cell-Free DNA Screening Product Offered
Table 47. Yourgene Health Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Yourgene Health Main Business
Table 49. Yourgene Health Latest Developments
Table 50. Illumina Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 51. Illumina Inc Prenatal Cell-Free DNA Screening Product Offered
Table 52. Illumina Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Illumina Inc Main Business
Table 54. Illumina Inc Latest Developments
Table 55. Agilent Technologies Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 56. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product Offered
Table 57. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Agilent Technologies Inc Main Business
Table 59. Agilent Technologies Inc Latest Developments
Table 60. Thermo Fisher Scientific Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product Offered
Table 62. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Inc Main Business
Table 64. Thermo Fisher Scientific Inc Latest Developments
Table 65. Hoffmann-La Roche Ltd Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 66. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product Offered
Table 67. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Hoffmann-La Roche Ltd Main Business
Table 69. Hoffmann-La Roche Ltd Latest Developments
Table 70. Laboratory Corporation of America Holdings Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 71. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product Offered
Table 72. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Laboratory Corporation of America Holdings Main Business
Table 74. Laboratory Corporation of America Holdings Latest Developments
Table 75. GE Healthcare Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 76. GE Healthcare Prenatal Cell-Free DNA Screening Product Offered
Table 77. GE Healthcare Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. GE Healthcare Main Business
Table 79. GE Healthcare Latest Developments
Table 80. PerkinElmer Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 81. PerkinElmer Inc Prenatal Cell-Free DNA Screening Product Offered
Table 82. PerkinElmer Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. PerkinElmer Inc Main Business
Table 84. PerkinElmer Inc Latest Developments
Table 85. BGI Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 86. BGI Prenatal Cell-Free DNA Screening Product Offered
Table 87. BGI Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. BGI Main Business
Table 89. BGI Latest Developments
Table 90. Natera Inc Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 91. Natera Inc Prenatal Cell-Free DNA Screening Product Offered
Table 92. Natera Inc Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Natera Inc Main Business
Table 94. Natera Inc Latest Developments
LIST OF FIGURES
Figure 1. Prenatal Cell-Free DNA Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Prenatal Cell-Free DNA Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2025)
Figure 8. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2025
Figure 10. Prenatal Cell-Free DNA Screening in Diagnostic Laboratories
Figure 11. Global Prenatal Cell-Free DNA Screening Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 12. Prenatal Cell-Free DNA Screening in Hospitals
Figure 13. Global Prenatal Cell-Free DNA Screening Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2025
Figure 15. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player in 2025
Figure 16. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 17. Americas Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 18. APAC Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 19. Europe Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 21. Americas Prenatal Cell-Free DNA Screening Value Market Share by Country in 2025
Figure 22. United States Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region in 2025
Figure 27. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 28. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 29. China Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. India Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country in 2025
Figure 36. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 37. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 38. Germany Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 39. France Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 52. APAC Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 53. Europe Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 55. United States Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 56. Canada Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 57. Mexico Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 58. Brazil Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 59. China Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 60. Japan Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 61. Korea Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 63. India Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 64. Australia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 65. Germany Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 66. France Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 67. UK Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 68. Italy Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 69. Russia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 70. Egypt Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 71. South Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 72. Israel Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 73. Turkey Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 74. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 1. Prenatal Cell-Free DNA Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Prenatal Cell-Free DNA Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2025)
Figure 8. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2025
Figure 10. Prenatal Cell-Free DNA Screening in Diagnostic Laboratories
Figure 11. Global Prenatal Cell-Free DNA Screening Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 12. Prenatal Cell-Free DNA Screening in Hospitals
Figure 13. Global Prenatal Cell-Free DNA Screening Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2025
Figure 15. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player in 2025
Figure 16. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 17. Americas Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 18. APAC Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 19. Europe Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 21. Americas Prenatal Cell-Free DNA Screening Value Market Share by Country in 2025
Figure 22. United States Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region in 2025
Figure 27. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 28. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 29. China Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. India Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country in 2025
Figure 36. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 37. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 38. Germany Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 39. France Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 52. APAC Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 53. Europe Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 55. United States Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 56. Canada Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 57. Mexico Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 58. Brazil Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 59. China Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 60. Japan Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 61. Korea Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 63. India Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 64. Australia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 65. Germany Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 66. France Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 67. UK Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 68. Italy Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 69. Russia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 70. Egypt Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 71. South Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 72. Israel Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 73. Turkey Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 74. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
